0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Acellular Pertussis Vaccines Available Soon For Fourth, Fifth Doses of DTP Immunization

Charles Marwick
JAMA. 1992;267(2):207-208. doi:10.1001/jama.1992.03480020017004.
Text Size: A A A
Published online

ABSTRACT

THE LONG-AWAITED acellular pertussis vaccines are about to become available for use in the fourth and fifth doses of the childhood diphtheria-tetanus-pertussis (DTP) immunization schedule.

Although there is no move at present to incorporate the acellular form of the vaccine into the first three doses of the routine childhood DTP immunization schedule, the coming licensure of these vaccines marks the first step toward their eventual availability for the entire DTP schedule. Studies are being done by manufacturers and the National Institutes of Health, Bethesda, Md, to test the safety and efficacy of these acellular agents when used in the first three doses.

In the meantime, an advisory committee of the Food and Drug Administration, Rockville, Md, having heard evidence from two manufacturers— Lederle Laboratories, Wayne, NJ, and Connaught Laboratories, Swiftwater, Pa—that the acellular vaccines are at least as immunogenic as the whole-cell product and have fewer untoward reactions, recommended fourth

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();